Catalogue Number: C3996-APE
Manufacturer: | Apexbio |
Physical state: | A crystalline solid |
Type: | Phosphatase Inhibitors |
Alias: | BR-1,P0108,Phosphatase of Regenerating Liver 3 Inhibitor,PTP4A3 Inhibitor |
Shipping Condition: | Blue Ice |
Storage Condition: | -70°C |
Unit(s): | 10 mg, 25 mg, 5 mg |
Description: IC50: 900 nM: blocks human phosphatase of regenerating liver 3 (PRL-3) in vitro.PRL-3 inhibitor, a cell-permeable benzylidene rhodamine compound, potently dampens PRL-3 and inhibits other phosphatases with minimal activity. It has been demonstrated that PRL-3 inhibitor can be used as therapeutics for the treatment of cancer. PRL-3 is a member of the regenerating liver family tyrosine phosphatases and plays vital roles in cell proliferation, migration, invasion, and motility, and thus leads to cancer metastasis.In vitro: PRL-3 inhibitor, in a dose-dependent fashion, blocked the dephosphorylation of DiFMUP by PRL-3 and strongly suppressed the activity of PRL-3 phosphatase in PRL-3 overexpressing DLD-1 colon tumor cells [DLD-1 (PRL-3)]. Also, PRL-3 inhibitor dose-dependently blocked the migration of DLD-1 (PRL-3) cells, however, it did not inhibit the proliferation of DLD-1(PRL-3) cells, suggesting that PRL-3 inhibitor significantly blocked cell immigration and invasion without cytotoxicity [1].In vivo: Up to now, in vivo study of PRL-3 Inhibitor is still in the development stage.Reference:[1]. Min, G., Lee, S., Kim, H., Han, Y., Lee, R., & Jeong, D. et al. Rhodanine-based PRL-3 inhibitors blocked the migration and invasion of metastatic cancer cells. Bioorganic & Medicinal Chemistry Letters. 2013; 23(13): 3769-3774.
phosphatase of regenerating liver 3 (PRL-3) inhibitor
≤16mg/ml in DMSO;16mg/ml in dimethyl formamide
BrC1=CC=C(OCC2=C(Br)C=CC=C2)C(/C=C3C(NC(S3)=S)=O)=C1
Store at -80°C